Bloodline

Education

BMT Reviews

CME Activities

Laboratory Hematology

Case Reports

Bloodline Reviews

Image Atlas

Resources

Supported by:

Bloodline - Hematology Education and News

Latest News Featured New Links

Massive Transfusion At Major Trauma Centers To Be Studied By UT Researchers
Initial Clinical Experience With A Novel Spectroscopy Catheter That Can Identify Lipid-core Coronary Plaques
Study Shows Once-Daily Exjade Removes Iron From The Heart In Transfused Patients With Beta-thalassaemia

Bloodline Image Atlas

Blood and Marrow Transplantation Reviews

1. The Crookston Collection (Slide Images)    (Category: References)
2. HEMEX Laboratories    (Category: Treatment and Research Centers)
3. BMTSAA    (Category: Organizations)
4. Non-Hodgkin's Lymphoma Cyberfamily    (Category: Patient Information)
5. WFCC-MIRCEN World Data Centre for Microorganisms (WDCM)    (Category: References)

View full link directory

CME Activities

Improving Outcomes in Chronic GvHD through Immune Regulation

Release date: May 2008

Expiration date: May 31, 2009

Estimated time to complete activity: 1.0 hours

Advancing CML Patient Care: Closing In on a Cure? A CME Webcast

Release date: April 2008

Expiration date: April 30, 2009

Estimated time to complete activity: 2.0 hours

The Promise of Epigenetic Therapy

The content of this continuing medical education (CME) activity is derived from a symposium, “The Promise of Epigenetic Therapy,” presented at the 48th Annual Meeting of the American Society of Hematology.

Extracorporeal Photopheresis: Defining a Role in the Treatment of Chronic GvHD

Graft-versus-host disease (GvHD) is a common side effect of an allogeneic bone marrow or cord blood transplant. This program discusses the results of treating chronic GvHD with extracorporeal photopheresis.

Current and Future Trends in HSCT: The Impact of Preparative Regimens

This CME activity will review current investigations of the myeloablative and nonmyeloablative preparative regimens used to minimize complications and adverse events, to minimize disease relapse, and to enhance long-term survival for patients with hematologic malignancies undergoing HSCT.

More...

<< Start < Prev 1 2 Next > End >>

Results 1 - 10 of 11

Bloodline Updates

RSS / Subscribe